Budesonide inhalation suspension 2000 mcg was compared in a randomized, double-blind, double dummy study against 1 mg/kg of oral prednisone. There was no difference in the pulmonary index admission ...
Viatris announced the launch of Breyna ™ (budesonide and formoterol fumarate dihydrate) inhalation aerosol, the first generic version of AstraZeneca’s Symbicort ®. Breyna is a metered-dose inhaler ...
Budesonide Inhalation Suspension, 0.5 mg/2 ml Single-Dose Ampule is indicated for maintenance treatment of asthma and as prophylactic therapy in children from 12 months old to 8 years. Aurbodino ...
PITTSBURGH and WOODBURY, Minn., July 31, 2023 /3BL/ - Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and ...
Research and Markets: Investigation Report on China's Budesonide (Pulmicort Respules) Market to 2018
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5rp48m/investigation) has announced the addition of the "Investigation ...
NEW YORK (Reuters) - AstraZeneca Plc and Teva Pharmaceutical Industries Ltd said on Tuesday they have reached a settlement in their patent infringement dispute over AstraZeneca's Pulmicort Respules ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback